Your browser doesn't support javascript.
Severe Hepatitis in Pediatric Coronavirus Disease 2019.
Antala, Swati; Diamond, Tamir; Kociolek, Larry K; Shah, Amit A; Chapin, Catherine A.
  • Antala S; Division of Gastroenterology, Hepatology and Nutrition, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Diamond T; Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA.
  • Kociolek LK; Division ofinfectious Diseases, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Shah AA; Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA.
  • Chapin CA; Division of Gastroenterology, Hepatology and Nutrition, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL.
J Pediatr Gastroenterol Nutr ; 74(5): 631-635, 2022 05 01.
Article in English | MEDLINE | ID: covidwho-1684905
ABSTRACT
ABSTRACT Hepatic involvement in coronavirus disease 2019 (COVID-19) is typically characterized as mild hepatitis with preserved synthetic function in children. Severe hepatitis is a rare complication of COVID-19 infection that has not been extensively described in the pediatric population. We report a case series of four previously healthy children who presented with significant hepatitis as the primary manifestation of COVID-19 infection. Two of these patients met criteria for acute liver failure. None of the patients had respiratory symptoms. One patient was found to have complement dysfunction resulting in microangiopathic features and was treated successfully with eculizumab. This case is in line with adult post-mortem data showing that more severe cases of hepatic dysfunction secondary to COVID-19 infection may be associated with complement activation and microangiopathic features. Liver function should be evaluated in cases of severe COVID-19, and severe acute respiratory syndrome coronavirus 2 infection should be considered as a cause of acute severe hepatitis even in patients without significant respiratory or other systemic symptoms.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Liver Failure, Acute / COVID-19 / Hepatitis Type of study: Experimental Studies Topics: Long Covid Limits: Adult / Child / Humans Language: English Journal: J Pediatr Gastroenterol Nutr Year: 2022 Document Type: Article Affiliation country: Mpg.0000000000003404

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Liver Failure, Acute / COVID-19 / Hepatitis Type of study: Experimental Studies Topics: Long Covid Limits: Adult / Child / Humans Language: English Journal: J Pediatr Gastroenterol Nutr Year: 2022 Document Type: Article Affiliation country: Mpg.0000000000003404